Sir, The production of carbapenemases or extended-spectrum b-lactamases (ESBLs) and/or AmpC b-lactamases coupled with porin loss are the most common mechanisms of carbapenem resistance in Klebsiella spp. 1, 2 Amino acid substitutions in the active site of GES-type ESBLs may enhance their spectrum of activity against carbapenems. The variants GES-2, -4, -5, -6 and -11 are able to hydrolyse imipenem; GES-5 hydrolyses this agent most efficiently. 1, 3, 4 To date, GES-5-producing Klebsiella pneumoniae has only been identified in Korea. 5 In this report we investigated the mechanisms responsible for carbapenem resistance in a K. pneumoniae subsp. ozaenae from Brazil.
KOZ-Ban2 was isolated from a rectal surveillance swab of an elderly patient admitted to a private hospital in Sã o Paulo, Brazil, in 2008. The patient was admitted with the diagnosis of community-acquired pneumonia and was successfully treated with piperacillin/tazobactam and moxifloxacin. Two weeks later, the patient presented a new episode of pneumonia that was empirically treated with meropenem and teicoplanin, with good clinical outcome. After 5 weeks of hospitalization, the patient was admitted to the intensive care unit with septic shock and respiratory failure. Candida sp. was isolated from the bloodstream at the same time that KOZ-Ban2 was recovered from the rectal swab. The patient died 24 h later.
KOZ-Ban2 identification was performed by the BD Phoenix TM Automated Microbiology System. Susceptibility testing was performed by CLSI agar dilution, 6 and showed that KOZ-Ban2 was resistant to all b-lactams including carbapenems, amikacin, gentamicin, nalidixic acid and ciprofloxacin (Table 1) .
PCR and amplicon sequencing, using previously reported conditions and primers specific for KPC-, MBL-and ESBL-encoding genes and the 5 0 and 3 0 conserved sequences of integrons, 7 identified the bla GES-5 gene. This gene was harboured in the first position of a class 1 integron, followed by the aacA4, bla OXA-17 , dfrA21 and catB3 cassettes, encoding an aminoglycoside acetyltransferase, an extended-spectrum oxacillinase capable of hydrolysing cefotaxime and cefepime better than ceftazidime, 8 a dihydrofolate reductase and a chloramphenicol acetyltransferase, respectively. This new integron, named In91, had a weak P c version with the sequence 235 TGGACA and 210 TAAGCT and an inactive P 2 (GQ139471). The search for plasmid-mediated quinolone resistance determinants yielded negative results.
PCR and sequencing of ompK35 and ompK36 genes revealed that the size of the ompK36 amplicon was 650 bp lower than expected. Sequencing showed that 674 bp was missing in KOZ-Ban2 ompK36 (GQ139473). In addition, although the ompK35 amplicon was the expected size, its sequencing revealed one change at position 689, where the codon TGG changed to the stop codon TAG, probably resulting in a deficient porin that lacked the last 130 amino acids (GQ139472). SDS -PAGE of outer membrane protein (OMP) profiles was performed as previously reported, 9 using a carbapenem-susceptible K. pneumoniae for comparison. The carbapenem-susceptible isolate showed three bands near the 36 kDa band of the molecular weight marker, whereas KOZ-Ban2 had a single band, probably corresponding to OmpA (data not shown). These findings suggest that neither OmpK35 nor OmpK36 was expressed in KOZ-Ban2.
Mating-out assays were performed using streptomycin-resistant Escherichia coli K12 as the recipient strain, and selection was performed on Mueller-Hinton agar plates containing 500 mg/L streptomycin and 50 mg/L ticarcillin. The presence of bla GES-5 in transconjugants was confirmed by PCR. Conjugation experiments revealed that bla GES-5 was carried by a self-conjugative plasmid of 37 kb. Although the transconjugant carrying bla GES-5 had low carbapenem MICs (Table 1) , a spectrophotometric assay, performed as previously described, 7 revealed that its crude extract had hydrolytic activity against imipenem (data not shown).
Our study constitutes the first report of GES-5-producing Klebsiella spp. on the American continent. The presence of antimicrobial resistance determinants coupled with OmpK35 and OmpK36 loss have contributed to the multidrug resistance phenotype observed. Clinical data analysis suggests that patient colonization by KOZ-Ban2 was probably favoured by previous b-lactam therapy.
Sir, Enzymatic inactivation mediated by aminoglycoside phosphotransferases (APHs), aminoglycoside nucleotidyltransferases (ANTs) or aminoglycoside acetyltransferases (AACs) is the most common mechanism of resistance to aminoglycosides identified among Gram-negative organisms. Among those resistance determinants, two acetyltransferases, AAC(6 0 )-Ib (which acetylates kanamycin, amikacin, tobramycin and netilmicin) and AAC(3)-II (which acts on kanamycin, tobramycin, netilmicin and gentamicin), and one adenyltransferase, ANT(2 00 )-I (which modifies kanamycin, tobramycin and gentamicin), are the most prevalent.
1 Since 2003, plasmid-mediated 16S rRNA methylases conferring high levels of resistance to all aminoglycosides that are used systemically (kanamycin, amikacin, tobramycin, netilmicin, gentamicin and isepamicin) have been described. Five of these enzymes methylate the G1405 of the A site of 16S ribosomal RNA (ArmA, RmtA, RmtB, RmtC and RmtD), whereas one (NpmA) methylates the A1408 of the A site of the 16S rRNA site. 2, 3 In this work, we have conducted an epidemiological survey to evaluate the prevalence of 16S rRNA methylases among extended-spectrum b-lactamase (ESBL)-producing Enterobacteriaceae collected from a Turkish hospital.
A collection of 139 non-repetitive and consecutive ESBLproducing enterobacterial clinical isolates was recovered from
